Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 2
1977 2
1978 3
1979 1
1980 2
1982 4
1983 2
1984 1
1986 1
1987 1
1988 2
1989 2
1991 2
1992 4
1993 3
1994 8
1995 9
1996 4
1997 5
1998 4
1999 12
2000 8
2001 6
2002 6
2003 6
2004 8
2005 2
2006 12
2007 10
2008 11
2009 18
2010 17
2011 15
2012 29
2013 28
2014 27
2015 44
2016 40
2017 48
2018 46
2019 61
2020 54
2021 48
2022 85
2023 53
2024 73
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group. Colombel JF, et al. N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492. N Engl J Med. 2010. PMID: 20393175 Free article. Clinical Trial.
Reply.
De Voogd F, D'Haens GR, Gecse KB. De Voogd F, et al. Gastroenterology. 2023 Jun;164(7):1347-1348. doi: 10.1053/j.gastro.2023.01.044. Epub 2023 Feb 17. Gastroenterology. 2023. PMID: 36801272 No abstract available.
Reply.
D'Haens GR, Sandborn WJ. D'Haens GR, et al. Gastroenterology. 2023 Jan;164(1):166-168. doi: 10.1053/j.gastro.2022.09.001. Epub 2022 Sep 5. Gastroenterology. 2023. PMID: 36067821 No abstract available.
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T, Loftus EV, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ. Vermeire S, et al. J Crohns Colitis. 2022 Jan 28;16(1):27-38. doi: 10.1093/ecco-jcc/jjab133. J Crohns Colitis. 2022. PMID: 34402887 Free PMC article. Clinical Trial.
725 results